The FX Super One and FF 91 2.0 will participate in the LA Auto Show, where our ride-along experiences begin. The Company welcomes everyone to give them a try and place preorders. LOS ANGELES, Nov. 23, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global shared intelligent electric mobility ecosystem company, today shared a weekly business update from YT Jia, Founder and Global Co-CEO of FF.   “Hi everyone, I’m ...

Shares of this quantum computing stock have soared over the past year. Is a stock split in the cards? While 2024 offered investors a number of stock splits, this year has provided notably fewer tech companies that have elected to split their stocks. But with the market's seemingly unyielding enthusiasm for quantum computing propelling many tech stocks sharply higher in 2025, many investors have been questioning whether stock-split activity may soon resume. Over the past year, for example, Quantum Computing ...

The Macquarie Group Ltd. logo at the company's headquarters in Sydney, Australia, on Wednesday, June 18, 2025.Australia's Qube Holdings announced on Monday that Macquarie Asset Management had submitted a non-binding proposal to acquire the logistics company at an enterprise value of 11.6 billion Australian dollars ($7.49 billion).Macquarie has offered to acquire Qube for AU$5.2 in cash per share, representing a nearly 28% premium to Qube's closing level of AU$4.07 on Friday.Qube shares jumped nearly 20% to ...

These Magnificent Seven players are well-positioned to benefit in the AI boom. Eli Lilly sells one of today's most sought-after products: weight loss drugs. Its blockbuster portfolio is driving revenue growth, and these drugs remain in high demand. Billionaire Stanley Druckenmiller is known for delivering long-term results to investors. At the helm of Duquesne Capital Management, he delivered an average annual return of 30% over three decades -- and never posted a money-losing year. That's why it's worth wa ...

After a volatile week of trading, Quantum Computing stock is now down 38% this year. Quantum Computing (QUBT 0.68%) stock pulled back over the last week of trading. The company's share price declined 3.8% in a stretch that saw the S&P 500's level decline 2% and the Nasdaq Composite's level fall 2.7%. The stock had been down double digits compared to its level at the previous week's market close, but it saw a big rebound later in Friday's session. On the heels of recent volatility, Quantum Computing stock is ...

Mark Zuckerberg, chief executive officer of Meta Platforms Inc., during a dinner with tech leaders in the State Dining Room of the White House in Washington, DC, US, on Thursday, Sept. 4, 2025. US President Donald Trump said he would be imposing tariffs on semiconductor imports "very shortly" but spare goods from companies like Apple Inc. that have pledged to boost their US investments. Photographer: Will Oliver/EPA/Bloomberg via Getty ImagesMeta halted internal research that purportedly showed that people ...

Core Insights - Harbour BioMed has advanced its global strategic collaboration with AstraZeneca to develop next-generation biotherapeutics, including antibody-drug conjugates and T cell engagers, leveraging both companies' expertise [1][3] Collaboration Details - AstraZeneca will nominate discovery programs to Harbour BioMed annually over the next four years, with the option to license these programs for further development. Harbour BioMed will receive option fees, milestone payments, and tiered royalties on future net sales [2] Company Background - Harbour BioMed is a global biopharmaceutical company focused on discovering and developing novel antibody therapeutics in immunology and oncology, building a robust pipeline through internal R&D, strategic collaborations, and selective acquisitions [4] Technology Platform - The company utilizes its proprietary Harbour Mice technology to generate fully human monoclonal antibodies in various formats, enabling the development of innovative biologics for treating significant medical needs [5]

Economists expect the rupee to appreciate by 100-150 paise from current levels to 88/$1 in the event of a positive trade deal, while further delay could push the currency towards 90 to 90.5 This week is expected to be volatile, with the rupee likely to trade in the 89-90 per dollar range, reflecting the immediate market reaction after the currency breached the psychological 89 level, unless the central bank again steps in to defend the 89.49 mark. "The narrow range seen in the past month has been broken on ...

Market Overview - US stock futures rose as investors anticipate a market turnaround in the Thanksgiving trading week, following a recent pullback in AI-driven stocks [1] - Major indexes have experienced notable losses in November, with the S&P 500 down 3.5% month-to-date and the Nasdaq Composite down 6.1% [2][3] Economic Indicators - The Federal Reserve Bank of New York president suggested a potential rate cut in December, contributing to Friday's market rebound [2] - Upcoming economic data releases include producer prices and retail sales for September, which are expected to provide insights into the economic landscape [4] Earnings Reports - The earnings season continues with key releases from companies such as Alibaba Holdings, Dell Technologies, and retailers like Kohl's and Best Buy during the holiday-shortened week [5]

This weekly habit could generate hundreds of thousands of dollars for you in the future.Investing small amounts of money wasn't always practical in the past. Commission fees were a big deterrent, and they would incentivize investors to put a lot of money in at once to minimize their impact. Now with commission-free trading options, however, it's easier than ever for investors to make much smaller investments without worrying about fees. This can be ideal if you're able to cut out some weekly expenditures fr ...